Pay in 4 interest-free payments of $6.54 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
From a pharmacological safety perspective, the adverse effect profile of retatrutide based on Phase 1 and Phase 2 clinical trial data (including the NEJM 2023 Phase 2 trial) includes: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (the most commonly reported side effects in trial participants) Injection site reactions: Redness, swelling, or discomfort at the injection site Cardiovascular effects: Increases in heart rate have been observed in trial participants [21] [22] Hypoglycaemia: Particularly relevant in individuals with diabetes or those taking insulin, sulfonylureas, or other glucose-lowering agents Potential thyroid effects: GLP-1 receptor agonists have been associated with thyroid C-cell changes in rodent studies
However, supplements don't seem to help
additionally, in the pathological state, it has also become a factor for the excitatory toxicity of glutamic acid
Routine step: Treatment
Each patient will receive a valid prescription, which is sent to the pharmacy to be filled
pH matters more
US$ 21.68
US$ 21.71
US$ 23.71
US$ 23.24
US$ 21.37
US$ 26.28
US$ 24.46
